Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9845472
SERIAL NO

15345463

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

PVT1 exon 9 is overexpressed in aggressively tumorigenic prostate cancer cell lines and prostate tumor tissues. This exon provides a diagnostic tool for the detection and monitoring of aggressive prostate cancer. Several small interfering ribonucleic acids (siRNAs) are disclosed that are useful for treating prostate cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK230 WEST 41ST STREET NEW YORK NY 10036-7207

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ilboudo, Adeodat Bronx, US 3 3
Ogunwobi, Olorunseun O Yonkers, US 7 4
Ying, Chunxiao Forest Hills, US 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00